Cm. Flores et al., DIFFERENTIAL REGULATION OF NEURONAL NICOTINIC RECEPTOR-BINDING SITES FOLLOWING CHRONIC NICOTINE ADMINISTRATION, Journal of neurochemistry, 69(5), 1997, pp. 2216-2219
Chronic nicotine administration to rats produces an increase in neuron
al nicotinic receptors in the CNS. Moreover, the up-regulated sites la
beled by [H-3]cytisine in cerebral cortex appear to be composed exclus
ively of alpha 4 and beta 2 subunits. It is unknown whether receptor s
ubtypes that do not bind [H-3]cytisine with high affinity are also aff
ected. In the present studies, we tested the hypothesis that nicotine
treatment differentially alters the density of neuronal nicotinic rece
ptor subtypes in rat nervous tissues. Thus, we compared the binding of
[H-3]cytisine with that of [H-3]epibatidine to nicotinic receptors in
brain, spinal cord, and adrenal gland from rats that had been injecte
d twice daily with nicotine or saline vehicle for 10 days. Chronic nic
otine treatment led to an increase in nicotinic receptor binding sites
in the cerebral cortex and in the dorsal lumbar spinal cord, but not
in the thalamus. It is important that virtually all of the observed in
creases could be accounted for by a selective effect on the fraction o
f receptors exhibiting high affinity for both [H-3]cytisine and [H-3]e
pibatidine. In contrast, no change in [H-3]epibatidine binding was see
n in the adrenal gland, a tissue that does not exhibit high-affinity [
H-3]cytisine binding. These data indicate that, under the conditions u
sed here, nicotine up-regulates the alpha 4 beta 2 nicotinic receptor
subtype, which can be labeled by [H-3]cytisine and [H-3]epibatidine, b
ut not non-alpha 4 beta 2 subtypes, which can be labeled by [H-3]epiba
tidine.